drugset / Trial / NCT02300155
Improving Multivitamin Supplementation to Pregnant Women
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the tolerability of Pregvit® to a common prenatal vitamin (Orifer® F) among pregnant women with morning sickness or those suffering from a variety of conditions.
Timeline
- Start
- 2004-10
- Primary completion
- 2006-10
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Orifer F® | Other / unclassified | 60 mg | — |
| Subject | PregVit® | Other / unclassified | 35 mg | — |